Other Clinical Trial - Post-Marketing Surveillance Study of Tolvaptan in

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04310319` - Wishing to Decrease Aquaresis in ADPKD Patients Treated With a V2Ra; the Effect of Regulating Protein and Salt	N/A
Completed	`NCT04363554` - The Kidneys Ability to Concentrate and Dilute Urine in Patients With Autosomal Dominant Polycystic Kidney Disease	N/A
Recruiting	`NCT05521191` - A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease	Phase 1
Completed	`NCT03687554` - Effect of Venglustat in Patients With Renal Impairment	Phase 1
Terminated	`NCT03523728` - A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients	Phase 2/Phase 3
Completed	`NCT00565097` - Lanreotide as Treatment of Polycystic Livers	Phase 2/Phase 3
Completed	`NCT00410007` - The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Autosomal Dominant Polycystic Kidney Disease	N/A
Completed	`NCT02251275` - Long Term Safety of Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease	Phase 3
Completed	`NCT01559363` - A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease	Phase 1/Phase 2
Completed	`NCT02903511` - Feasibility Study of Metformin Therapy in ADPKD	Phase 2
Completed	`NCT00456365` - Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)	Phase 3
Recruiting	`NCT05510115` - Feasibility of Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease	Phase 2
Completed	`NCT02494141` - Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKD	Phase 4
Completed	`NCT04407481` - PErfusioN, OxyGen ConsUmptIon and ENergetics in ADPKD (PENGUIN)
Completed	`NCT03342742` - Daily Caloric Restriction and Intermittent Fasting in Overweight and Obese Adults With Autosomal Dominant Polycystic Kidney Disease	N/A
Completed	`NCT02656017` - Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease	Phase 2
Completed	`NCT04023214` - The Role of Endothelial Dysfunction in Adult Polycystic Kidney Disease
Terminated	`NCT01589705` - The Relation Between Uric Acid Level and Endothelial Dysfunction in Patients With Polycystic Kidney Disease	N/A
Completed	`NCT00426153` - Octreotide in Severe Polycystic Liver Disease	Phase 2/Phase 3
Completed	`NCT04534985` - Time Restricted Feeding in Autosomal Dominant Polycystic Kidney Disease	N/A

NCT number	NCT02847624
Study type	Observational
Source	Otsuka Pharmaceutical Co., Ltd.
Contact
Status	Completed
Phase
Start date	March 24, 2014
Completion date	September 20, 2022

Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms